Speakers


Keynote Speakers

Kate Bingham

Kate Bingham

Read more

Managing Director, SV Health Investors , Former Chair, UK Vaccine Task Force (Until January 2021)

John Reed, M.D., Ph.D.

John Reed, M.D., Ph.D.

Read more

Executive Vice President, Global Head of Research & Development, Sanofi

Moncef Slaoui

Moncef Slaoui

Read more

Partner, Medicxi | Former Scientific head of Operation Warp Speed (Until January 2021)

Conference Speakers & Panelists

Devang Bhuva

Devang Bhuva

Read more

Senior Vice President, Corporate Development at Gilead Sciences

Marianne De Backer, PhD, MBA

Marianne De Backer, PhD, MBA

Read more

EVP Global Head, Strategy & Business Development, Bayer

Francesco De Rubertis

Francesco De Rubertis

Read more

Co-founder and Partner, Medicxi

Janeen Doyle

Janeen Doyle

Read more

VP, Head of Research & Early Dev Alliance Management, Bristol-Myers Squibb

Jessica Droge

Jessica Droge

Read more

Vice President, Business Development at Amgen

Stephen C. Ferruolo

Stephen C. Ferruolo

Read more

Partner, Perkins Coie

Simone Fishburn, PhD

Simone Fishburn, PhD

Read more

Vice President and Editor in Chief, BioCentury

Carol Gallagher

Carol Gallagher

Read more

Partner, New Enterprise Associates, Inc. (NEA)

George S. Golumbeski

George S. Golumbeski

Read more

Executive Advisor/board member of KSQ Therapeutics; Board member of Carrick Therapeutics. formerly, Senior Vice President of Business Development for Celgene Corporation

Jason Hafler

Jason Hafler

Read more

Managing Director, Sanofi Ventures

Reza Halse

Reza Halse

Read more

President, Merck Research Labs Ventures Fund

Sean Harper, MD

Sean Harper, MD

Read more

Managing Director, Westlake Village Biopartners®

Faheem Hasnain

Faheem Hasnain

Read more

CEO, Gossamer Bio

Richard Heyman

Richard Heyman

Read more

Executive Chairman and Co-founder, Metacrine Inc.

Nina Kjellson

Nina Kjellson

Read more

General Partner/West Coast, Canaan

Jim Krenn

Jim Krenn

Read more

Partner, Morrison & Foerster LLP

Angele Maki, PhD

Angele Maki, PhD

Read more

Vice President of Emerging Technology & Innovation, Eli Lilly

Oleg Nodelman

Oleg Nodelman

Read more

Founder and Managing Director of EcoR1 Capital Fund

Carole Nuechterlein

Carole Nuechterlein

Read more

Head, Roche Venture Fund

Merdad Parsey

Merdad Parsey

Read more

Chief Medical Officer, Gilead Sciences 

Heather Preston

Heather Preston

Read more

Managing Partner, Pivotal

Kyle Rasbach

Kyle Rasbach

Read more

Managing Partner, Pappas Ventures

Terry Rosen

Terry Rosen

Read more

Chief Executive Officer, Arcus

Ioannis Sapountzis, PhD

Ioannis Sapountzis, PhD

Read more

Corporate Senior Vice President, Business Development, Boehringer Ingelheim Pharmaceuticals, Inc.

Uwe Schoenbeck, PhD

Uwe Schoenbeck, PhD

Read more

Senior Vice President and Chief Scientific Officer, Emerging Science and Innovation (ES&I), Pfizer Worldwide Research, Development, and Medical

Andrew Schwab

Andrew Schwab

Read more

Founder & Managing Partner, 5AM Ventures

Armen Shanafelt, Ph.D.

Armen Shanafelt, Ph.D.

Read more

General Partner, Lilly Ventures

Nigel Sheail

Nigel Sheail

Read more

Global Head Mergers & Acquisitions and Business Development & Licensing, Novartis

Jason M. Skolnik

Jason M. Skolnik

Read more

Partner, Wilson Sonsini Goodrich & Rosati

Kumar Srinivasan

Kumar Srinivasan

Read more

Vice President, Global Head of Business Development & Licensing, Biopharmaceuticals R&D, AstraZeneca

Jay Stamatis, MBA

Jay Stamatis, MBA

Read more

VP & Head of Global Business Development & Acquisitions, Abbvie

Alex Szidon, PhD

Alex Szidon, PhD

Read more

Vice President and Head of Business Development, gRED at Genentech

Ben Thorner

Ben Thorner

Read more

Senior Vice President, Business Development and Licensing, Merck Research Laboratories

Arda Ural

Arda Ural

Read more

Americas Life Science & Healthcare Markets Leader, Ernst & Young

Jeffrey Warmke, PhD

Jeffrey Warmke, PhD

Read more

Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo